Literature DB >> 32170749

Annexin A6 Is Critical to Maintain Glucose Homeostasis and Survival During Liver Regeneration in Mice.

Anna Alvarez-Guaita1,2, Patricia Blanco-Muñoz1,3, Elsa Meneses-Salas1,3, Mohamed Wahba4, Abigail H Pollock5, Jaimy Jose4, Mercedes Casado6, Marta Bosch3, Rafael Artuch6, Katharina Gaus5, Albert Lu7, Albert Pol3,8, Francesc Tebar1,3, Stephen E Moss9, Thomas Grewal4, Carlos Enrich1,3, Carles Rentero1,3.   

Abstract

BACKGROUND AND AIMS: Liver regeneration requires the organized and sequential activation of events that lead to restoration of hepatic mass. During this process, other vital liver functions need to be preserved, such as maintenance of blood glucose homeostasis, balancing the degradation of hepatic glycogen stores, and gluconeogenesis (GNG). Under metabolic stress, alanine is the main hepatic gluconeogenic substrate, and its availability is the rate-limiting step in this pathway. Na+ -coupled neutral amino acid transporters (SNATs) 2 and 4 are believed to facilitate hepatic alanine uptake. In previous studies, we demonstrated that a member of the Ca2+ -dependent phospholipid binding annexins, Annexin A6 (AnxA6), regulates membrane trafficking along endo- and exocytic pathways. Yet, although AnxA6 is abundantly expressed in the liver, its function in hepatic physiology remains unknown. In this study, we investigated the potential contribution of AnxA6 in liver regeneration. APPROACH AND
RESULTS: Utilizing AnxA6 knockout mice (AnxA6-/- ), we challenged liver function after partial hepatectomy (PHx), inducing acute proliferative and metabolic stress. Biochemical and immunofluorescent approaches were used to dissect AnxA6-/- mice liver proliferation and energetic metabolism. Most strikingly, AnxA6-/- mice exhibited low survival after PHx. This was associated with an irreversible and progressive drop of blood glucose levels. Whereas exogenous glucose administration or restoration of hepatic AnxA6 expression rescued AnxA6-/- mice survival after PHx, the sustained hypoglycemia in partially hepatectomized AnxA6-/- mice was the consequence of an impaired alanine-dependent GNG in AnxA6-/- hepatocytes. Mechanistically, cytoplasmic SNAT4 failed to recycle to the sinusoidal plasma membrane of AnxA6-/- hepatocytes 48 hours after PHx, impairing alanine uptake and, consequently, glucose production.
CONCLUSIONS: We conclude that the lack of AnxA6 compromises alanine-dependent GNG and liver regeneration in mice.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2020        PMID: 32170749     DOI: 10.1002/hep.31232

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

Review 1.  Annexin Animal Models-From Fundamental Principles to Translational Research.

Authors:  Thomas Grewal; Carles Rentero; Carlos Enrich; Mohamed Wahba; Carsten A Raabe; Ursula Rescher
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

Review 2.  Annexins Bridging the Gap: Novel Roles in Membrane Contact Site Formation.

Authors:  Carlos Enrich; Albert Lu; Francesc Tebar; Carles Rentero; Thomas Grewal
Journal:  Front Cell Dev Biol       Date:  2022-01-06

3.  Reduced Expression of Annexin A6 Induces Metabolic Reprogramming That Favors Rapid Fatty Acid Oxidation in Triple-Negative Breast Cancer Cells.

Authors:  Stephen D Williams; Amos M Sakwe
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.575

4.  Hypoxia-Inducible Expression of Annexin A6 Enhances the Resistance of Triple-Negative Breast Cancer Cells to EGFR and AR Antagonists.

Authors:  Stephen D Williams; Tunde M Smith; LaMonica V Stewart; Amos M Sakwe
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

Review 5.  Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies.

Authors:  Olga Y Korolkova; Sarrah E Widatalla; Stephen D Williams; Diva S Whalen; Heather K Beasley; Josiah Ochieng; Thomas Grewal; Amos M Sakwe
Journal:  Cells       Date:  2020-08-07       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.